Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 5Phase 1/2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Leukemia 41Breast Neoplasms 28Lymphoma 21Leukemia, Myeloid, Acute 16Burkitt Lymphoma 13Myelodysplastic Syndromes 11Graft vs Host Disease 10Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Biphenotypic, Acute 7Squamous Cell Carcinoma of Head and Neck 6Urinary Bladder Neoplasms 5Leukemia, Promyelocytic, Acute 5Hodgkin Disease 5Anemia, Refractory, with Excess of Blasts 5Osteosarcoma 4Myeloproliferative Disorders 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Head and Neck Neoplasms 4Arthritis, Rheumatoid 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Methotrexate × Clear all
NCT02688140 2026-05-29

TUD-APOLLO-064

Technische Universität Dresden

Phase 3 Completed
133 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00492856 2023-01-10

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

SWOG Cancer Research Network

Phase 3 Completed
105 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00482833 2022-10-12

APL0406

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 3 Completed
276 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003934 2013-06-05

Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
420 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡